Invention Grant
- Patent Title: Methods, compositions, and uses of novel FYN kinase inhibitors
-
Application No.: US16896663Application Date: 2020-06-09
-
Publication No.: US11701353B2Publication Date: 2023-07-18
- Inventor: Warren C. Lau
- Applicant: Pathways Neuro Pharma, Inc.
- Applicant Address: US TX Tomball
- Assignee: Pathways Neuro Pharma, Inc.
- Current Assignee: Pathways Neuro Pharma, Inc.
- Current Assignee Address: US TX Tomball
- Agency: Perkins Coie LLP
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/4985 ; A61K31/497 ; C12N9/12 ; A61K31/4436 ; A61K31/444 ; A61K31/496 ; A61K31/4965 ; A61K31/5025 ; A61K31/519 ; A61K31/5377

Abstract:
The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
Public/Granted literature
- US20210030753A1 Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors Public/Granted day:2021-02-04
Information query